-
Company Insights
![]()
Innovation and Patenting activity of Revenio Group Oyj Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Revenio Group Oyj Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Profile
![]()
Revenio Group Oyj – Company Profile
Revenio Group Oyj (Revenio) is a provider of health tech screening devices related to ophthalmic diagnostic solutions. The company focuses on early detection of glaucoma, asthma, skin cancer and macular degeneration. The company's major products include devices for detecting age-related eye diseases which include glaucoma, diabetic retinopathy, macular degeneration and cataracts. Revenio offers its products to ophthalmologists, opticians, and optometrists. The company has operations in Europe, America, and Asia. Revenio is headquartered in Vantaa, Finland.
Add to Basket
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.